Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Pat…

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Gunnison Copper Reports Positive Results from Limestone Evaluation to Add New By-Product Revenue at the Gunnison Project in Southeast Arizona

Analyzed Limestone Meets Industrial Specifications for Several Saleable Products, Unlocking Value for Updated PEA Expected in Q1 2026Phoenix, Arizona--(Newsfile Corp. - October 23, 2025) - Gunnison ...